Company profile: Scorpion Therapeutics
1.1 - Company Overview
Company description
- Provider of clinical-stage precision oncology therapeutics, developing small-molecule inhibitors targeting the H1047X-mutant PI3Kα in solid tumors (STX-H1047-PI3Kα) and exon 20 insertion mutations in EGFR driving non-small cell lung cancer (STX-EGFR-EXON20).
Products and services
- STX-EGFR-EXON20: A selectivity-optimized small molecule that selectively targets EGFR exon 20 insertion mutations driving non-small cell lung cancer (NSCLC)
- STX-H1047-PI3Kα: A mutation-specific small molecule that targets the H1047X-mutant form of PI3Kα associated with solid tumors
- Precision Oncology Development: A clinical-stage program at Scorpion Therapeutics specializing in precision medicine for cancer patients within oncology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Scorpion Therapeutics
EpiCapture
HQ: Ireland
Website
- Description: Provider of accurate, non-invasive urine tests to detect aggressive cancers, focused on improving cancer patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EpiCapture company profile →
Forbius
HQ: United States
Website
- Description: Provider of clinical-stage biotherapeutics for the treatment of cancer and fibrotic diseases, developing agents that target the transforming growth factor-beta (TGF-beta) and epidermal growth factor receptor (EGFR) pathways.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Forbius company profile →
Medfusion Services
HQ: United States
Website
- Description: Provider of integrated clinical laboratory and clinical trial services, offering diagnostic testing (solid tumor, hematopathology, women's health, urology, general health), molecular diagnostics and test development, pathology services, and clinical trial support including specimen collection, processing, testing, and guidance for specimen packaging and shipping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medfusion Services company profile →
Piramed
HQ: United Kingdom
Website
- Description: Provider of inhibitor-focused drug discovery and development of new medicines targeting cancer and immune inflammatory disorders, with applications across cardiovascular disease and pain.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Piramed company profile →
Boundless Bio
HQ: United States
Website
- Description: Provider of precision oncology therapeutics and diagnostics targeting extrachromosomal DNA (ecDNA) in aggressive cancers, including BBI-355 (oral CHK1 inhibitor for ecDNA-enabled oncogene amplified cells), BBI-825 (oral RNR inhibitor disrupting ecDNA assembly and repair), the Spyglass platform to identify and validate druggable targets in ecDNA-cancer cells, and ECHO to detect ecDNA from routine clinical next-generation sequencing data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boundless Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Scorpion Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Scorpion Therapeutics
2.2 - Growth funds investing in similar companies to Scorpion Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Scorpion Therapeutics
4.2 - Public trading comparable groups for Scorpion Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →